Repository logo
Institutional Digital Repository
Shreenivas Deshpande Library, IIT (BHU), Varanasi

Natural Products and some Semi-synthetic Analogues as Potential TRPV1 Ligands for Attenuating Neuropathic Pain

dc.contributor.authorNaik G.G.; Uniyal A.; Chouhan D.; Tiwari V.; Sahu A.N.
dc.date.accessioned2025-05-23T11:23:46Z
dc.description.abstractNatural products and leads inspired by them have acted as a probe for successful drug discovery for many decades. Pain is an obnoxious sensory and emotional experience associated with potential tissue damage. It affects the quality of life of patients to a greater extent. Despite the availability of several agents targeting TRP receptors, none of them can proficiently alleviate neuropathic pain. TRPV1 is a prospective target for treating neuropathic pain as it is recognized to modulate the pain circuitry at the periphery and the central level. In this review, we have discussed several natural molecules, such as Capsaicinoids, Capsinoids, Piperine, Eugenol, Scutigeral, Ginsenosides, Cinnamaldehyde, Camphor, Shogaol, Gingerols, Zingerone, Allicin, Evodiamine, Allylisothiocyanate, Cannabidiol, Ricinoleic acid, Isovelleral, Capsazepine, Thapsigargin, Pellitorine, Yohimbine, Curcumin and some semi-synthetic analogues that activate TRPV1 channels and consequently, can be further harnessed for the treatment of neuropathic pain. © 2022 Bentham Science Publishers.
dc.identifier.doihttps://doi.org/10.2174/1389201022666210719155931
dc.identifier.urihttp://172.23.0.11:4000/handle/123456789/9346
dc.relation.ispartofseriesCurrent Pharmaceutical Biotechnology
dc.titleNatural Products and some Semi-synthetic Analogues as Potential TRPV1 Ligands for Attenuating Neuropathic Pain

Files

Collections